DK1574209T3 - Fremgangsmåde til behandling af ophthalmiske sygdomme - Google Patents
Fremgangsmåde til behandling af ophthalmiske sygdommeInfo
- Publication number
- DK1574209T3 DK1574209T3 DK05010733.3T DK05010733T DK1574209T3 DK 1574209 T3 DK1574209 T3 DK 1574209T3 DK 05010733 T DK05010733 T DK 05010733T DK 1574209 T3 DK1574209 T3 DK 1574209T3
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- treatment
- ophthalmic diseases
- image
- periocularly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/620,982 US5904144A (en) | 1996-03-22 | 1996-03-22 | Method for treating ophthalmic diseases |
EP97916936A EP0927024B8 (en) | 1996-03-22 | 1997-03-24 | Device and method for treating ophthalmic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1574209T3 true DK1574209T3 (da) | 2010-05-31 |
Family
ID=24488233
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97916936T DK0927024T3 (da) | 1996-03-22 | 1997-03-24 | Indretning og fremgangsmåde til behandling af öjensygdomme |
DK05010733.3T DK1574209T3 (da) | 1996-03-22 | 1997-03-24 | Fremgangsmåde til behandling af ophthalmiske sygdomme |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97916936T DK0927024T3 (da) | 1996-03-22 | 1997-03-24 | Indretning og fremgangsmåde til behandling af öjensygdomme |
Country Status (10)
Country | Link |
---|---|
US (1) | US5904144A (da) |
EP (2) | EP1574209B1 (da) |
JP (3) | JP2000507854A (da) |
AT (2) | ATE296087T1 (da) |
AU (1) | AU716400B2 (da) |
CA (1) | CA2264895C (da) |
DE (2) | DE69739792D1 (da) |
DK (2) | DK0927024T3 (da) |
ES (2) | ES2242223T3 (da) |
WO (1) | WO1997034586A2 (da) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6299895B1 (en) * | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
EP0958831A4 (en) | 1996-09-13 | 2004-04-07 | Advanced Medicine Res Inst | OPHTHALMIC COMPOSITIONS OF NEUROTROPHIC FACTORS, REMEDIES FOR FUNCTIONAL OPTIC NERVE DISORDERS AND METHOD FOR TREATING SUCH DISORDERS |
DE19718826A1 (de) * | 1997-05-05 | 1998-11-12 | Marion S Dr Eckmiller | Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung |
WO1999013868A1 (en) * | 1997-09-17 | 1999-03-25 | Alcon Laboratories, Inc. | Methods for treating ocular diseases |
US7282482B2 (en) * | 1998-04-08 | 2007-10-16 | The Regents Of The University Of California | NGF for the prevention of demyelination in the nervous system |
JP2002534139A (ja) * | 1999-01-05 | 2002-10-15 | マサチューセッツ・アイ・アンド・イア・インファーマリー | 網膜と脈絡膜への経強膜徐放性薬剤標的送達 |
US20070071734A1 (en) * | 1999-04-06 | 2007-03-29 | Weng Tao | ARPE-19 as platform cell line for encapsulated cell-based delivery |
US6361771B1 (en) * | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
EP1179061B1 (en) * | 1999-05-07 | 2006-09-20 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Methods for treating tumors using antiangiogenic compounds |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
DE60040876D1 (de) * | 1999-10-21 | 2009-01-02 | Alcon Inc | Medikamentenzuführeinrichtung |
DE60018777T2 (de) | 1999-10-21 | 2006-02-02 | Alcon Inc. | Medikamentenversorgung der sub-tenon |
US6267954B1 (en) * | 1999-11-24 | 2001-07-31 | Universite De Paris V Rene-Descartes | Intraocular transplantation of encapsulated cells |
CA2398571A1 (en) * | 2000-02-11 | 2001-08-16 | Genvec, Inc. | Materials and methods for treating ocular-related disorders |
EP1313415B1 (en) * | 2000-08-30 | 2008-08-13 | Johns Hopkins University | Devices for intraocular drug delivery |
US6697668B2 (en) * | 2001-01-25 | 2004-02-24 | Iomed, Inc. | Ocular iontophoretic device and method for using the same |
US6546284B2 (en) * | 2001-01-25 | 2003-04-08 | Iomed, Inc. | Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same |
US7181287B2 (en) * | 2001-02-13 | 2007-02-20 | Second Sight Medical Products, Inc. | Implantable drug delivery device |
US6875165B2 (en) * | 2001-02-22 | 2005-04-05 | Retinalabs, Inc. | Method of radiation delivery to the eye |
JP2004536631A (ja) | 2001-05-03 | 2004-12-09 | マサチューセッツ・アイ・アンド・イア・インファーマリー | 移植可能な薬物送達デバイスおよびその使用 |
WO2002100318A2 (en) | 2001-06-12 | 2002-12-19 | Johns Hopkins University School Of Medicine | Reservoir device for intraocular drug delivery |
US20050033202A1 (en) * | 2001-06-29 | 2005-02-10 | Chow Alan Y. | Mechanically activated objects for treatment of degenerative retinal disease |
US7031776B2 (en) * | 2001-06-29 | 2006-04-18 | Optobionics | Methods for improving damaged retinal cell function |
DE10133870A1 (de) * | 2001-07-12 | 2003-02-06 | Chris P Lohmann | Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge |
ES2271301T3 (es) * | 2001-07-23 | 2007-04-16 | Alcon, Inc. | Dispositivo de suministro de farmaco oftalmico. |
PT1409065E (pt) | 2001-07-23 | 2007-03-30 | Alcon Inc | Dispositivo de administração de fármacos oftálmicos |
HUP0401605A3 (en) * | 2001-08-01 | 2012-09-28 | Merck Patent Gmbh | Integrin inhibitors for the treatment of eye diseases |
WO2003092665A2 (en) * | 2002-05-02 | 2003-11-13 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
CA2689424A1 (en) * | 2002-09-29 | 2004-04-08 | Surmodics, Inc. | Methods for treatment and/or prevention of retinal disease |
US20060167435A1 (en) * | 2003-02-18 | 2006-07-27 | Adamis Anthony P | Transscleral drug delivery device and related methods |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
JP4824549B2 (ja) * | 2003-05-02 | 2011-11-30 | サーモディクス,インコーポレイティド | 制御放出型の生体活性物質デリバリー・デバイス |
DE602004028769D1 (de) | 2003-06-10 | 2010-09-30 | Nsgene As | Verbesserte Sekretion von Neublastin |
CA2522592A1 (en) * | 2003-07-10 | 2005-02-03 | Alcon, Inc. | Ophthalmic drug delivery device |
JP2007505932A (ja) * | 2003-09-18 | 2007-03-15 | マクサイト, インコーポレイテッド | 経強膜送達 |
EP2210617A1 (en) | 2003-10-20 | 2010-07-28 | NsGene A/S | Mammalian cells secreting Neurturin and their therapeutic use |
US20050136095A1 (en) * | 2003-12-22 | 2005-06-23 | Brian Levy | Drug delivery device with suture ring |
IL159818A0 (en) * | 2004-01-12 | 2004-06-20 | Nulens Ltd | Intraocular structure |
US7563222B2 (en) * | 2004-02-12 | 2009-07-21 | Neovista, Inc. | Methods and apparatus for intraocular brachytherapy |
EP1720608B1 (en) * | 2004-02-12 | 2010-11-17 | NeoVista, Inc. | Apparatus for intraocular brachytherapy |
WO2005095450A2 (en) | 2004-03-30 | 2005-10-13 | Nsgene A/S | Therapeutic use of a growth factor, nsg33 |
US20060024350A1 (en) * | 2004-06-24 | 2006-02-02 | Varner Signe E | Biodegradable ocular devices, methods and systems |
US20060110428A1 (en) * | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
US20090136552A1 (en) * | 2004-07-30 | 2009-05-28 | Mette Gronborg | Growth factors nsg28, nsg30, and nsg32 |
WO2006023130A2 (en) * | 2004-08-12 | 2006-03-02 | Surmodics, Inc. | Biodegradable controlled release bioactive agent delivery device |
US8246569B1 (en) | 2004-08-17 | 2012-08-21 | California Institute Of Technology | Implantable intraocular pressure drain |
EA200700772A1 (ru) * | 2004-10-04 | 2007-10-26 | Селгейт, Инк. | Аналоги полиаминов в качестве терапевтических средств для глазных заболеваний |
ES2564194T3 (es) | 2005-02-09 | 2016-03-18 | Santen Pharmaceutical Co., Ltd. | Formulaciones líquidas para el tratamiento de enfermedades o dolencias |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
TW200640443A (en) * | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
US20060233858A1 (en) * | 2005-03-08 | 2006-10-19 | Allergan, Inc. | Systems and methods providing targeted intraocular drug delivery |
US20070077270A1 (en) * | 2005-03-28 | 2007-04-05 | Clemson University | Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear |
CA2603391A1 (en) | 2005-04-01 | 2006-10-05 | Nsgene A/S | A human immortalised neural precursor cell line |
CN101180086A (zh) * | 2005-04-08 | 2008-05-14 | 苏尔莫迪克斯公司 | 用于经视网膜下递送的持续释放植入物 |
US20060258994A1 (en) * | 2005-05-12 | 2006-11-16 | Avery Robert L | Implantable delivery device for administering pharmacological agents to an internal portion of a body |
EP1883446B8 (en) | 2005-05-17 | 2017-11-15 | Gloria Therapeutics Sarl | An implantable therapy system for treating a living being with an active factor |
US8309057B2 (en) * | 2005-06-10 | 2012-11-13 | The Invention Science Fund I, Llc | Methods for elevating neurotrophic agents |
AU2006272497B2 (en) | 2005-07-27 | 2012-07-19 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
BRPI0618677A2 (pt) | 2005-11-15 | 2011-09-06 | Neovista Inc | métodos e aparelho para braquiterapia intra-ocular |
WO2007064752A2 (en) | 2005-11-29 | 2007-06-07 | Smithkline Beecham Corporation | Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
ES2406716T3 (es) * | 2005-12-30 | 2013-06-07 | Neurotech Usa, Inc. | Dispositivo micronizado para el suministro de moléculas activas biológicamente y método de uso del mismo |
CA2636068A1 (en) * | 2006-01-17 | 2007-07-26 | Nulens Ltd | Intraocular drug dispenser |
BRPI0707612B8 (pt) | 2006-02-09 | 2021-05-25 | Macusight Inc | vaso lacrado e formulações líquidas contidas no mesmo |
EP1998829B1 (en) * | 2006-03-14 | 2011-02-09 | University Of Southern California | Mems device for delivery of therapeutic agents |
AU2007230964B2 (en) | 2006-03-23 | 2012-07-19 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
US20080145406A1 (en) * | 2006-12-18 | 2008-06-19 | Alcon Manufacturing Ltd. | Devices and methods for ophthalmic drug delivery |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
JP5542691B2 (ja) * | 2007-12-20 | 2014-07-09 | ユニバーシティ オブ サザン カリフォルニア | 治療薬を送達するための装置および方法 |
MX2010007382A (es) * | 2008-01-03 | 2010-12-20 | Univ Southern California | Dispositivos implantables para suministro de farmacos, y aparato y metodos para recargar los dispositivos. |
MX2010012213A (es) * | 2008-05-08 | 2011-05-03 | Minipumps Llc | Bombas implantables y cánulas para las mismas. |
US8231608B2 (en) | 2008-05-08 | 2012-07-31 | Minipumps, Llc | Drug-delivery pumps and methods of manufacture |
CN102202706A (zh) | 2008-05-08 | 2011-09-28 | 迷你泵有限责任公司 | 可植入药物传送装置与用于填充该装置的设备和方法 |
US9333297B2 (en) | 2008-05-08 | 2016-05-10 | Minipumps, Llc | Drug-delivery pump with intelligent control |
WO2009149175A1 (en) | 2008-06-04 | 2009-12-10 | Neovista, Inc. | Handheld radiation delivery system for advancing a radiation source wire |
US20120021039A1 (en) | 2009-01-23 | 2012-01-26 | Nsgene A/S | Expression of neuropeptides in mammalian cells |
AU2010206374B2 (en) | 2009-01-23 | 2013-01-17 | Gloriana Therapeutics Sarl | Improved cell lines and their use in encapsulated cell biodelivery |
US8372036B2 (en) * | 2009-05-06 | 2013-02-12 | Alcon Research, Ltd. | Multi-layer heat assembly for a drug delivery device |
IN2012DN00352A (da) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
AU2010284216B2 (en) * | 2009-08-18 | 2015-10-15 | Minipumps, Llc | Electrolytic drug-delivery pump with adaptive control |
WO2011039648A1 (en) | 2009-09-30 | 2011-04-07 | Glaxo Wellcome Manufacturing Pte Ltd. | Methods of administration and treatment |
US8177747B2 (en) * | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
AU2011307663B2 (en) | 2010-09-27 | 2015-05-07 | Gloriana Therapeutics Sarl | Implantable cell device with supportive and radial diffusive scaffolding |
EP2621512B1 (en) | 2010-10-01 | 2016-04-06 | NsGene A/S | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
US9603997B2 (en) | 2011-03-14 | 2017-03-28 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US9919099B2 (en) | 2011-03-14 | 2018-03-20 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US10286146B2 (en) | 2011-03-14 | 2019-05-14 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
EP2720539B1 (en) | 2011-06-14 | 2018-10-24 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
WO2013034157A1 (en) | 2011-09-05 | 2013-03-14 | Nsgene A/S | Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
CA2856703A1 (en) | 2011-10-19 | 2013-04-25 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
EP2944628B1 (en) | 2011-11-30 | 2017-01-04 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
EP2785178B1 (en) | 2011-12-01 | 2019-05-01 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
RU2494711C1 (ru) * | 2012-05-18 | 2013-10-10 | Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации | Способ хирургического лечения прогрессирующей и осложненной миопии |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
EP2855030B1 (en) | 2012-06-01 | 2019-08-21 | SurModics, Inc. | Apparatus and method for coating balloon catheters |
US11090468B2 (en) | 2012-10-25 | 2021-08-17 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
EP3043836B1 (en) | 2013-09-11 | 2023-05-10 | Neurotech USA, Inc. | Encapsulated cell therapy cartridge |
CA2967330A1 (en) | 2014-11-10 | 2016-05-19 | Forsight Vision4, Inc. | Expandable drug delivery devices and methods of use |
WO2017176886A1 (en) | 2016-04-05 | 2017-10-12 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
US11628466B2 (en) | 2018-11-29 | 2023-04-18 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US20240180686A1 (en) * | 2019-11-01 | 2024-06-06 | Neurotech Usa, Inc. | System, apparatuses, devices, and methods for an analyte diffusive implantable device |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5116798A (ja) * | 1974-08-01 | 1976-02-10 | Mihairoichi Kurasunofu Mihairu | Jinkosuishotai |
US5266562A (en) * | 1987-11-19 | 1993-11-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-inflammatory agents |
US5521215A (en) * | 1989-11-07 | 1996-05-28 | Ramot University Authority For Applied Research And Industrial Development Ltd. | NMDA-blocking pharmaceuticals |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5382514A (en) * | 1992-03-31 | 1995-01-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | In vivo angiogenesis assay |
US5178635A (en) * | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US5279298A (en) * | 1992-11-20 | 1994-01-18 | The Johns Hopkins University | Method and apparatus to identify and treat neovascular membranes in the eye |
US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US5550050A (en) * | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
US5466233A (en) * | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
US5472436A (en) * | 1994-07-26 | 1995-12-05 | Fremstad; Daria A. | Ocular appliance for delivering medication |
-
1996
- 1996-03-22 US US08/620,982 patent/US5904144A/en not_active Expired - Lifetime
-
1997
- 1997-03-24 DE DE69739792T patent/DE69739792D1/de not_active Expired - Lifetime
- 1997-03-24 ES ES97916936T patent/ES2242223T3/es not_active Expired - Lifetime
- 1997-03-24 DE DE69733357T patent/DE69733357T2/de not_active Expired - Lifetime
- 1997-03-24 EP EP05010733A patent/EP1574209B1/en not_active Expired - Lifetime
- 1997-03-24 JP JP9533777A patent/JP2000507854A/ja not_active Withdrawn
- 1997-03-24 AT AT97916936T patent/ATE296087T1/de active
- 1997-03-24 WO PCT/US1997/004701 patent/WO1997034586A2/en active IP Right Grant
- 1997-03-24 EP EP97916936A patent/EP0927024B8/en not_active Expired - Lifetime
- 1997-03-24 ES ES05010733T patent/ES2342075T3/es not_active Expired - Lifetime
- 1997-03-24 AT AT05010733T patent/ATE459335T1/de not_active IP Right Cessation
- 1997-03-24 DK DK97916936T patent/DK0927024T3/da active
- 1997-03-24 AU AU25419/97A patent/AU716400B2/en not_active Ceased
- 1997-03-24 CA CA002264895A patent/CA2264895C/en not_active Expired - Fee Related
- 1997-03-24 DK DK05010733.3T patent/DK1574209T3/da active
-
2006
- 2006-09-13 JP JP2006248673A patent/JP4740077B2/ja not_active Expired - Lifetime
-
2010
- 2010-08-19 JP JP2010184490A patent/JP2010265314A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0927024B8 (en) | 2005-08-31 |
ATE296087T1 (de) | 2005-06-15 |
EP1574209A1 (en) | 2005-09-14 |
EP0927024B1 (en) | 2005-05-25 |
AU2541997A (en) | 1997-10-10 |
EP1574209B1 (en) | 2010-03-03 |
ES2242223T3 (es) | 2005-11-01 |
WO1997034586A2 (en) | 1997-09-25 |
JP2010265314A (ja) | 2010-11-25 |
CA2264895C (en) | 2008-05-27 |
JP2006342185A (ja) | 2006-12-21 |
DE69733357D1 (de) | 2005-06-30 |
DE69739792D1 (de) | 2010-04-15 |
CA2264895A1 (en) | 1997-09-25 |
US5904144A (en) | 1999-05-18 |
DK0927024T3 (da) | 2005-08-29 |
JP2000507854A (ja) | 2000-06-27 |
ES2342075T3 (es) | 2010-07-01 |
JP4740077B2 (ja) | 2011-08-03 |
EP0927024A2 (en) | 1999-07-07 |
AU716400B2 (en) | 2000-02-24 |
ATE459335T1 (de) | 2010-03-15 |
WO1997034586A3 (en) | 1997-10-23 |
DE69733357T2 (de) | 2006-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1574209T3 (da) | Fremgangsmåde til behandling af ophthalmiske sygdomme | |
LU90869I2 (fr) | Olanzapine - l'-tat amorphe (zyprexa) | |
ATE229806T1 (de) | Wirkstoff zur behandlung neurodegenerativer störungen | |
DK0668763T3 (da) | Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme | |
DE69825292D1 (de) | Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen | |
NO992755D0 (no) | Protese for °yets senehinne for behandling av presbyopi og andre forstyrrelser i °yner | |
DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
IL128877A0 (en) | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias | |
DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
WO1997003188A3 (de) | Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems | |
DK1726651T3 (da) | Fremgangsmåde til behandling af muskulære lidelser | |
DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
DE69614577D1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
DK1304107T3 (da) | Anvendelse af oxozolidinonderivater til behandling af psoriasis | |
FR2697753B3 (fr) | Composition ophtalmique destinée au traitement de la sécheresse oculaire, l'entretien des lentilles de contact et à l'utilisation comme excipient de collyres. | |
IT8919216A0 (it) | Dispositivo per la cura chirurgica dell'astigmatismo. | |
ES1028766Y (es) | Dispositivo para tratamiento ocular. | |
DE59404213D1 (de) | Trainingsgerät zur Behandlung von an Wahrnehmungsstörungen leidenden Patienten |